Mehta on the Phase 3 METIS Trial of TTFields for Brain Metastases in NSCLCByMinesh Mehta, MDJune 6th 2024Minesh Mehta, MD, discusses positive findings from the phase 3 METIS trial investigating TTFields therapy for brain metastases in NSCLC.